Nicholas Hoffman & Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.53M Sell
17,340
-4
-0% -$342 0.03% 109
2026
Q2
$1.34M Buy
17,344
+50
+0.3% +$3.65K 0.03% 124
2026
Q1
$1.13M Buy
17,294
+9,188
+113% +$682K 0.03% 136
2025
Q4
$642K Sell
8,106
-18
-0.2% -$1.38K 0.01% 194
2025
Q3
$593K Sell
8,124
-32
-0.4% -$2.35K 0.01% 200
2025
Q2
$619K Sell
8,156
-136
-2% -$9.6K 0.02% 191
2025
Q1
$631K Buy
8,292
+1,678
+25% +$125K 0.02% 174
2024
Q4
$437K Sell
6,614
-19
-0.3% -$1.33K 0.02% 204
2024
Q3
$462K Sell
6,633
-65
-1% -$3.91K 0.02% 211
2024
Q2
$354K Buy
+6,698
New +$407K 0.02% 220

Other funds holding SOLV

Nicholas Hoffman & Company's SOLV Position: Q3 2026 in Review

Nicholas Hoffman & Company reduced its Solventum (SOLV) stake by 0.02% in Q3 2026, selling an estimated $342 and leaving 17,340 shares worth $1.53M. The position accounts for 0.03% of the portfolio, ranked #109.

Nicholas Hoffman & Company first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. 899 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Nicholas Hoffman & Company held 17,340 shares of Solventum worth $1.53M as of Q3 2026.
  • Nicholas Hoffman & Company sold 4 Solventum shares in Q3 2026, an estimated $342.
  • Solventum made up 0.03% of Nicholas Hoffman & Company's portfolio in Q3 2026, its #109 holding.
  • Nicholas Hoffman & Company first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • 899 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q3 2026, filed 30 Oct 2026.